Why Qualys, Inc. (QLYS) Stock Fell 13.5% on Nov 10, 2026
as of Tuesday, 4:48 PM ET
The reason we found
Qualys Falls Despite Earnings Beat on Tepid Revenue Outlook
Qualys exceeded third-quarter earnings and revenue expectations and raised 2026 guidance, but its next-quarter revenue outlook was only slightly above consensus. Investors appear to be treating the modest forecast upside as insufficient, sending shares sharply lower despite strong profitability and federal-sector demand.
earnings and guidancehigh confidence
Sources 13
- Qualys Q3 Earnings Beat on Federal Strength, 2026 Guidance Raisedfinnhub.io
- Qualys (QLYS) Q3 earnings: what to expectfinnhub.io
- Qualys (QLYS) Expands Global MROC Alliance Across Mobile OT IoT And Identityfinnhub.io
- Qualys (QLYS) Raises Guidance, Is The Stock Already Overvalued?finnhub.io
- Qualys to Speak at Upcoming Investor Conferencefinnhub.io
- Cybersecurity Pullback Exposes Split Between Quality-Value and High-Multiple Growthfinnhub.io
- Qualys Earnings Beat, Revenue Edges By Estimatesfinnhub.io
- Qualys (NASDAQ:QLYS) beats Q3 2026 sales expectations but stock dropsfinance.yahoo.com
- Qualys (NASDAQ:QLYS) beats Q3 2026 sales expectations but stock dropsfinnhub.io
- Qualys Earnings Beat. Cybersecurity Stock Falls On Revenue Outlook.finnhub.io
- Qualys: Q3 Earnings Snapshotfinnhub.io
- Qualys Announces Third Quarter 2026 Financial Resultsfinnhub.io
- Lookout Accelerates Mobile Attack Surface Defense Against AI-Driven Threats with Qualys Enterprise TruRisk Managementfinnhub.io
Our call
Buy moredated Nov 11, 2026
Qualys fell 13% over the past five trading days after its Nov 9 report beat profit forecasts by 14%, but its sales grew 10% over the past year. We'd stop buying if Qualys' next report shows sales growth below 5% or misses profit forecasts.
Other moves on Nov 10
- HIMS−16.5%Earnings miss and weaker outlook trigger Hims & Hers selloff
- LFVN−13.6%LifeVantage Stock Falls After Revenue Drops 22%
- ACAD+10.7%Revenue Beat and Guidance Lift Acadia Shares
- ASTS−8.7%AST SpaceMobile slides after earnings miss and price-target cut
- BDSX−8.5%Analyst trims Biodesix target despite maintaining Buy rating
- SERV−8.4%Analyst lowers Serve Robotics price target, pressuring shares